Recombinant Hepatitis B Vaccine (CHO Cell) (Ausper Biopharma)
重组乙型肝炎疫苗（CHO细胞）
Report date: 2026/05/21 20:00:22
Base Information
Drug NameRecombinant Hepatitis B Vaccine (CHO Cell) (Ausper Biopharma)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesAusper Biopharma Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesAusper Biopharma Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A